Alkem Laboratories Limited
ALKEM
Rangering i aksjer
#2905
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aksjekurs
$52.51
Markedsverdi
$6.28B
Endring (1 dag)
-4.86%
Endring (1 år)
-16.69%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Inntekter for Alkem Laboratories Limited (ALKEM)
Inntekter i Jun 2026 TTM: $1.66B
Ifølge de nyeste økonomiske rapportene til Alkem Laboratories Limited er selskapets nåværende inntekter (TTM) $1.66B. I 2025 hadde selskapet inntekter på $1.50B en økning sammenlignet med inntektene i 2024, som var $1.49B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Alkem Laboratories Limited fra 2010 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $1.66B | 11.17% |
| 2025 | $1.50B | 0.36% |
| 2024 | $1.49B | 7.16% |
| 2023 | $1.39B | 0.53% |
| 2022 | $1.38B | 16.14% |
| 2021 | $1.19B | 9.65% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 8.08% |
| 2018 | $968.16M | 11.79% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 22.45% |
| 2013 | $419.09M | 10.73% |
| 2012 | $378.47M | 2.07% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 297.25% |
IN
|
